India’s orthopedic market is growing, driven by an aging population, fast-paced urban lifestyles, and a greater awareness of joint health. For Zimmer Biomet India, a subsidiary of the Warsaw, Indiana-based company, the goal of orthopedic care in India has evolved beyond simply fixing injuries. The company’s messaging is now about helping people regain their independence, and overall quality of life. (Gunjan note: My aging relatives in India certainly were driven by their need to regain independence before agreeing to bilateral knee replacements). In India the company faces strong competition from J&J India and other global companies; India based companies are also becoming better at some segments of the market.
The company’s commitment to this mission was showcased at its recent event, ZB Next, held in New Delhi and Mumbai. Zimmer Biomet India introduced nine new technologies aimed at “remodeling” orthopedic care in the country.
Ajay Bagga, Managing Director of Zimmer Biomet India
According to Ajay Bagga, managing director of Zimmer Biomet India, “We’re launching advanced platforms in robotics, navigation, AI-powered planning, and smart implants. This portfolio, spanning hip, knee, and shoulder segments, is designed to empower surgeons with enhanced precision, optimize patient outcomes, and support the entire continuum of care, from pre-operative planning through post-operative recovery.
Featured innovations within this portfolio include mymobility, an AI-powered digital care management platform; ROSA Partial Knee and ROSA Hip, robotic-assisted surgical systems; G7 Acetabular System; RibFix Blu Thoracic Fixation System; Comprehensive Micro Stems; Comprehensive Augmented Base Plate; Signature ONE Version 2 Planning Software; and Tricera System.
Bagga believes that through collaboration among industry leaders, policymakers, and healthcare providers, India can become a pioneer in inclusive, tech-driven healthcare solutions.
Last updated: December 26th, 2025
